The rise and rise of Staphylococcus aureus: Laughing in the face of granulocytes

Clinical and Experimental Immunology

Volumn 157, Issue 2, 2009, Pages 216-224

  Anwar, S ^a   Prince, L R ^a   Foster, S J ^a   Whyte, M K B ^a   Sabroe, I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Apoptosis; Inflammation; Necrosis; Neutrophil; S. aureus

Indexed keywords

MICROBICIDE;

ANTIBIOTIC RESISTANCE; APOPTOSIS; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL FUNCTION; CELL SURVIVAL; GRANULOCYTE; HOST PATHOGEN INTERACTION; INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ABSCESS; CELL DEATH; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOCYTE COUNT; NEUTROPHILS; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 67650666159     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03950.x     Document Type: Review

References (109)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998 339 : 520 32.
2. Wertheim HF, Melles DC, Vos MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005 5 : 751 62.
3. van Belkum A, Melles DC, Nouwen J et al. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 2008 9 : 32 47.
4. Health Protection Agency. Surveillance of Healthcare Associated Infections Report. 2008. Available at: http://www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb-C/1216193832294 (accessed July 2008).
5. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006 333 : 281.
6. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005 5 : 275 86.
7. Chambers HF. Community-associated MRSA - resistance and virulence converge. N Engl J Med 2005 352 : 1485 7.
8. Hampton MB, Kettle AJ, Winterbourn CC. Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. Infect Immun 1996 64 : 3512 17.
9. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005 23 : 197 223. (Pubitemid 40563169)
10. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science 2004 303 : 1532 5.
11. Fuchs TA, Abed U, Goosmann C et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007 176 : 231 41.
12. Spickett GP. Immune deficiency disorders involving neutrophils. J Clin Pathol 2008 61 : 1001 5.
13. Lakshman R, Finn A. Neutrophil disorders and their management. J Clin Pathol 2001 54 : 7 19. (Pubitemid 32048289)
14. Abramson JS, Mills EL, Sawyer MK, Regelmann WR, Nelson JD, Quie PG. Recurrent infections and delayed separation of the umbilical cord in an infant with abnormal phagocytic cell locomotion and oxidative response during particle phagocytosis. J Pediatr 1981 99 : 887 94.
15. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Balt) 2000 79 : 170 200. (Pubitemid 30327531)
16. Liese J, Kloos S, Jendrossek V et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000 137 : 687 93.
17. Reeves EP, Lu H, Jacobs HL et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002 416 : 291 7.
18. Miller LS, Pietras EM, Uricchio LH et al. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol 2007 179 : 6933 42.
19. Caver TE, O'Sullivan FX, Gold LI, Gresham HD. Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. J Clin Invest 1996 98 : 2496 506.
20. Kielian T, Barry B, Hickey WF. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol 2001 166 : 4634 43.
21. Molne L, Verdrengh M, Tarkowski A. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 2000 68 : 6162 7.
22. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005 3 : 948 58.
23. Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol 2005 13 : 596 601. (Pubitemid 41661341)
24. Wergeland HI, Haaheim LR, Natas OB, Wesenberg F, Oeding P. Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J Clin Microbiol 1989 27 : 1286 91.
25. Gjertsson I, Hultgren OH, Stenson M, Holmdahl R, Tarkowski A. Are B lymphocytes of importance in severe Staphylococcus aureus infections? Infect Immun 2000 68 : 2431 4.
26. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005 40 (Suppl. 4 S240 5.
27. Bera A, Herbert S, Jakob A, Vollmer W, Gotz F. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 2005 55 : 778 87.
28. Liu GY, Essex A, Buchanan JT et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 2005 202 : 209 15.
29. Palazzolo-Ballance AM, Reniere ML, Braughton KR et al. Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol 2008 180 : 500 9.
30. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000 164 : 3713 22.
31. McLoughlin RM, Lee JC, Kasper DL, Tzianabos AO. IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol 2008 181 : 1323 32.
32. McLoughlin RM, Solinga RM, Rich J et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci USA 2006 103 : 10408 13.
33. Voyich JM, Braughton KR, Sturdevant DE et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005 175 : 3907 19.
34. Kubica M, Guzik K, Koziel J et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 2008 3 : e1409.
35. Bianchi SM, Dockrell DH, Renshaw SA, Sabroe I, Whyte MK. Granulocyte apoptosis in the pathogenesis and resolution of lung disease. Clin Sci (Lond) 2006 110 : 293 304. (Pubitemid 43341631)
36. Haslett C. Granulocyte apoptosis and inflammatory disease. Br Med Bull 1997 53 : 669 83.
37. Hirsch T, Marchetti P, Susin SA et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997 15 : 1573 81.
38. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003 102 : 2660 9.
39. Kurt-Jones EA, Mandell L, Whitney C et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 2002 100 : 1860 8.
40. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999 274 : 17406 9.
41. Gonzalez-Zorn B, Senna JP, Fiette L et al. Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect Immun 2005 73 : 1847 51.
42. Hoebe K, Georgel P, Rutschmann S et al. CD36 is a sensor of diacylglycerides. Nature 2005 433 : 523 7.
43. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000 165 : 5392 6.
44. von Bernuth H, Picard C, Jin Z et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008 321 : 691 6.
45. Ku CL, von Bernuth H, Picard C et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007 204 : 2407 22.
46. Hajjar AM, O'Mahony DS, Ozinsky A et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 2001 166 : 15 19. (Pubitemid 32038411)
47. Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003 278 : 8869 72.
48. Deshmukh HS, Hamburger JB, Ahn SH, McCafferty DG, Yang SR, Fowler VG, Jr. The critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect Immun 2009 77 : 1376 82.
49. Kawai T, Akira S. TLR signaling. Cell Death Differ 2006 13 : 816 25.
50. Lotz S, Aga E, Wilde I et al. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leukoc Biol 2004 75 : 467 77.
51. Sabroe I, Prince LR, Jones EC et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003 170 : 5268 75.
52. Kobayashi SD, Braughton KR, Whitney AR et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003 100 : 10948 53.
53. Coxon A, Rieu P, Barkalow FJ et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996 5 : 653 66.
54. Yamamoto A, Taniuchi S, Tsuji S, Hasui M, Kobayashi Y. Role of reactive oxygen species in neutrophil apoptosis following ingestion of heat-killed Staphylococcus aureus. Clin Exp Immunol 2002 129 : 479 84.
55. Ocana MG, Asensi V, Montes AH, Meana A, Celada A, Valle-Garay E. Autoregulation mechanism of human neutrophil apoptosis during bacterial infection. Mol Immunol 2008 45 : 2087 96.
56. Luo HR, Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol 2008 83 : 288 95.
57. Prince LR, Allen L, Jones EC et al. The role of interleukin-1beta in direct and toll-like receptor 4-mediated neutrophil activation and survival. Am J Pathol 2004 165 : 1819 26.
58. Morris GE, Whyte MK, Martin GF, Jose PJ, Dower SK, Sabroe I. Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am J Respir Crit Care Med 2005 171 : 814 22.
59. Lundqvist-Gustafsson H, Norrman S, Nilsson J, Wilsson A. Involvement of p38-mitogen-activated protein kinase in Staphylococcus aureus-induced neutrophil apoptosis. J Leukoc Biol 2001 70 : 642 8.
60. Genestier AL, Michallet MC, Prevost G et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005 115 : 3117 27.
61. Hartl D, Latzin P, Hordijk P et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007 13 : 1423 30.
62. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev 1991 55 : 733 51.
63. Menestrina G, Dalla Serra M, Comai M et al. Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Lett 2003 552 : 54 60. (Pubitemid 37103009)
64. Menestrina G, Serra MD, Prevost G. Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon 2001 39 : 1661 72.
65. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008 205 : 287 94.
66. McElroy MC, Harty HR, Hosford GE, Boylan GM, Pittet JF, Foster TJ. Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 1999 67 : 5541 4.
67. Nilsson IM, Hartford O, Foster T, Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 1999 67 : 1045 9.
68. Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 1987 55 : 3103 10.
69. Valeva A, Walev I, Pinkernell M et al. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci USA 1997 94 : 11607 11.
70. Suttorp N, Seeger W, Zucker-Reimann J, Roka L, Bhakdi S. Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin. Infect Immun 1987 55 : 104 10.
71. Feinmark SJ, Cannon PJ. Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986 261 : 16466 72.
72. Grimminger F, Thomas M, Obernitz R, Walmrath D, Bhakdi S, Seeger W. Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature. J Exp Med 1990 172 : 1115 25.
73. Grandel U, Reutemann M, Kiss L et al. Staphylococcal alpha-toxin provokes neutrophil-dependent cardiac dysfunction: role of ICAM-1 and cys-leukotrienes. Am J Physiol Heart Circ Physiol 2002 282 : H1157 65.
74. Huseby M, Shi K, Brown CK et al. Structure and biological activities of beta toxin from Staphylococcus aureus. J Bacteriol 2007 189 : 8719 26.
75. Marshall MJ, Bohach GA, Boehm DF. Characterization of Staphylococcus aureus beta-toxin induced leukotoxicity. J Nat Toxins 2000 9 : 125 38.
76. Tajima A, Seki K, Shinji H, Masuda S. Inhibition of interleukin-8 production in human endothelial cells by Staphylococcus aureus supernatant. Clin Exp Immunol 2007 147 : 148 54.
77. O'Callaghan RJ, Callegan MC, Moreau JM et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun 1997 65 : 1571 8.
78. Schmitz FJ, Veldkamp KE, Van Kessel KP, Verhoef J, Van Strijp JA. Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst. J Infect Dis 1997 176 : 1531 7.
79. Kasimir S, Schonfeld W, Alouf JE, Konig W. Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism. Infect Immun 1990 58 : 1653 9.
80. Raulf M, Alouf JE, Konig W. Effect of staphylococcal delta-toxin and bee venom peptide melittin on leukotriene induction and metabolism of human polymorphonuclear granulocytes. Infect Immun 1990 58 : 2678 82.
81. Prevost G, Cribier B, Couppie P et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 1995 63 : 4121 9.
82. Staali L, Monteil H, Colin DA. The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils. J Membr Biol 1998 162 : 209 16.
83. Szmigielski S, Sobiczewska E, Prevost G, Monteil H, Colin DA, Jeljaszewicz J. Effect of purified staphylococcal leukocidal toxins on isolated blood polymorphonuclear leukocytes and peritoneal macrophages in vitro. Zentralbl Bakteriol 1998 288 : 383 94.
84. Clyne M, Azavedo J DE, Carlson E, Arbuthnott J. Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome. J Clin Microbiol 1988 26 : 535 9.
85. Supersac G, Piemont Y, Kubina M, Prevost G, Foster TJ. Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog 1998 24 : 241 51.
86. Colin DA, Mazurier I, Sire S, Finck-Barbancon V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect Immun 1994 62 : 3184 8.
87. Baba Moussa L, Werner S, Colin DA et al. Discoupling the Ca(2+)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs. FEBS Lett 1999 461 : 280 6.
88. Konig B, Prevost G, Piemont Y, Konig W. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995 171 : 607 13.
89. Hensler T, Konig B, Prevost G, Piemont Y, Koller M, Konig W. Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun 1994 62 : 2529 35.
90. Colin DA, Monteil H. Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 2003 71 : 3724 9.
91. Woodin AM. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 1960 75 : 158 65.
92. Gillet Y, Issartel B, Vanhems P et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002 359 : 753 9.
93. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999 29 : 1128 32.
94. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007 13 : 594 600. (Pubitemid 46525107)
95. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003 9 : 978 84.
96. Labandeira-Rey M, Couzon F, Boisset S et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007 315 : 1130 3.
97. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008 198 : 1166 70.
98. Voyich JM, Otto M, Mathema B et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006 194 : 1761 70.
99. Diep BA, Palazzolo-Ballance AM, Tattevin P et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 2008 3 : e3198.
100. Liles WC, Thomsen AR, O'Mahony DS, Klebanoff SJ. Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J Leukoc Biol 2001 70 : 96 102. (Pubitemid 32613668)
101. Wang R, Braughton KR, Kretschmer D et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007 13 : 1510 14.
102. Jarry TM, Memmi G, Cheung AL. The expression of alpha-haemolysin is required for Staphylococcus aureus phagosomal escape after internalization in CFT-1 cells. Cell Microbiol 2008 10 : 1801 14.
103. Rooijakkers SH, Ruyken M, van Roon J, van Kessel KP, van Strijp JA, van Wamel WJ. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol 2006 8 : 1282 93.
104. de Haas CJ, Veldkamp KE, Peschel A et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004 199 : 687 95.
105. Veldkamp KE, Heezius HC, Verhoef J, van Strijp JA, van Kessel KP. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate. Infect Immun 2000 68 : 5908 13.
106. Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 2007 204 : 2461 71.
107. Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett 2006 258 : 290 6.
108. Haggar A, Ehrnfelt C, Holgersson J, Flock JI. The extracellular adherence protein from Staphylococcus aureus inhibits neutrophil binding to endothelial cells. Infect Immun 2004 72 : 6164 7.
109. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004 172 : 1169 76.